Quick Review,Peptides should be stored in a dry, cool, dark place

The term "peptide carry over" refers to the undesirable phenomenon where residual amounts of a peptide from a previous injection or sample preparation process contaminate subsequent analyses or applications. This can significantly impact the accuracy and reliability of scientific experiments, particularly in fields like proteomics, pharmaceutical development, and analytical chemistry. Effectively managing and minimizing peptide carry over is crucial for obtaining precise results.

One of the primary culprits identified in the scientific literature, specifically in nano LC-MS/MS analysis of proteomics samples, is reversed-phase column technology. The nature of these columns, designed for separating complex mixtures of peptides, can sometimes lead to the retention of small amounts of analytes that are then released in subsequent runs. This necessitates careful method development and optimization, as highlighted in studies investigating carryover and contamination causes and cures.

Causes and Mitigation Strategies for Peptide Carry Over

Several factors can contribute to peptide carry over. Poor HPLC maintenance is frequently cited as a significant cause, alongside issues like sticky samples or poor solubility of the peptides themselves. When peptides do not dissolve completely or adhere to surfaces, they are more likely to persist and cause contamination.

To combat this, researchers have developed and optimized various cleaning methods. For instance, specific cleaning protocols have been designed to eliminate carryover caused by autosamplers and trap columns in nano LC systems. The addition of certain substances, such as trifluoroethanol, has been reported to prevent the carryover of peptides and proteins. Furthermore, the proper selection of reversed-phase, superficially porous particle HPLC columns is paramount to providing instruments with peptides at the highest quality and reducing carry over.

Another critical aspect is the presence of an analyte detected in the adjacent chromatographic run originating from the previous injection(s). This definition underscores the sequential nature of the problem and the need for meticulous procedural control. Advanced analytical techniques, such as LC-MS/MS analysis, require a deep understanding of these potential interferences. For example, specific troubleshooting efforts have been documented for the carry-over of neuropeptide Y (NPY) in LC-MS analysis, aiming to systematically remove problematic components of the LC-MS system.

Practical Considerations for Peptide Handling and Storage

Beyond analytical procedures, the physical handling and storage of peptides also play a role in preventing contamination and ensuring their stability. Peptides should be stored in a dry, cool, dark place. For optimal preservation, storage at 4°C or colder, away from bright light, is recommended. In lyophilized (freeze-dried) powder form, peptides can remain stable for several months to years if stored correctly. This stability is crucial for researchers who may need to store samples for extended periods.

Traveling with Peptides

For individuals who need to travel with peptides, especially those requiring refrigeration, specific guidelines exist. The Transportation Security Administration (TSA) generally allows you to travel with injectable liquid medication in your carry-on (or checked) luggage, provided you adhere to all of their guidelines. It is strongly advised to keep peptides in your carry-on luggage, never checking them, to maintain temperature control and ensure they are readily accessible. Specialized peptide vial storage solutions exist, with some cases specially designed to store up to 30 vials and even featuring fridge-friendly designs for easy storage in hotel refrigerators. When traveling, ensuring your ice packs remain frozen is a key concern, as confirmed by travelers who have been stopped by TSA for their peptides.

In summary, managing peptide carry over involves a multi-faceted approach, encompassing meticulous analytical practices, appropriate peptide handling and storage, and adherence to travel regulations. By understanding the causes and implementing effective mitigation strategies, researchers and individuals can ensure the integrity and accuracy of their work and personal use of peptides.